Johnson & Johnson

NYSE: JNJ · Real-Time Price · USD
156.10
1.64 (1.06%)
At close: May 02, 2025, 9:44 AM
1.06%
Bid 156.1
Market Cap 376.18B
Revenue (ttm) 89.33B
Net Income (ttm) 21.81B
EPS (ttm) 8.99
PE Ratio (ttm) 17.36
Forward PE 14.16
Analyst Buy
Ask 156.12
Volume 395,460
Avg. Volume (20D) 9,691,675
Open 156.07
Previous Close 154.46
Day's Range 155.19 - 156.12
52-Week Range 140.68 - 169.99
Beta 0.48

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED co...

Sector Healthcare
IPO Date Jan 2, 1943
Employees 138,100
Stock Exchange NYSE
Ticker Symbol JNJ
Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $169, which is an increase of 8.26% from the latest price.

Stock Forecasts
1 month ago
-7.59%
Johnson & Johnson shares are trading lower after a... Unlock content with Pro Subscription
6 months ago
+1.55%
Johnson & Johnson shares are trading higher after the company reported better-than-expected Q3 financial results.